Skip to content

Rapid Verbal Persuasion to Increase Influenza Vaccine Uptake: a Randomized Hybrid Type 2 Effectiveness -Implementation Trial

Rapid Verbal Persuasion to Increase Influenza Vaccine Uptake: a Randomized Hybrid Type 2 Effectiveness -Implementation Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091302
Enrollment
Unknown
Registered
2024-10-25
Start date
2024-10-28
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

Rapid Verbal Persuasion Experiment Group:When individuals visit the vaccination clinic for vaccination, consultation, or to accompany others for vaccination, the vaccination staff will conduct rapid v
the Standard Practice Group without RVP:When individuals visit the vaccination clinic for vaccination, consultation, or to accompany others for vaccination, the vaccination staff will not conduct rapi
Incentive Control Group :None (Without any incentive interventions)
Incentive Combination 1 :Flat upfront compensation
Incentive Combination 2:Performance bonus
Incentive Combination 3:Focused discussions
Incentive Combination 4:Public Recognition
Incentive Combination 5:Flat upfront compensation+Performance bonus
Incentive Combination 6:Flat upfront compensation+Focused discussions
Incentive Combination 7:Flat upfront compensation+Public Recognition
Incentive Combination 8:Performance bonus+Focused discussions
Incentive Combination 9:Performance bonus+Public Recognition
Incentive Combination 10:Focused discussions+Public Recognition
Incentive Combination 11:Flat upfront compensation+Focused discussions+Public Recognition
Incentive Combination 12:Flat upfront compensation+Performance bonus+Focused discussions
Incentive Combination 13:Flat upfront compensation+Performance bonus+Public Recognition
Incentive Combination 14:Performance bonus+Focused discussions+Public Recognition
Incentive Combination 15:Flat upfront compensation+Performance bonus+Focused discussions+Public Recognition

Sponsors

Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 100 Years

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for study settings: (1) Hospitals at all levels, community health centers, community health stations, township health centers with vaccination clinics, and village clinics certified for immunizations. 2.Target population for the rapid verbal persuasion intervention on influenza vaccination: (1) Individuals visiting above vaccination clinics for vaccination, as well as those seeking consultation or accompanying others for vaccination (regardless of the type of vaccine); (2) Aged =6 months with no contraindications to influenza vaccination. 3.Target population for the incentive-based implementation strategy: (1) Practicing (assistant) physicians, practicing (assistant) nurses, and other types of healthcare providers working in above healthcare instituions; (2) Engaged in vaccination-related work for =6 months.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria for study settings: (1) those who are engaged in other intervention studies aimed at increasing the influenza vaccine rate; (2) those who are involved in other implementation studies about incentives; (3) those who are beneficiaries of subsidies from vaccine companies. 2.Target population for the rapid verbal persuasion intervention on influenza vaccination: (1)Individuals proactively coming for influenza vaccination; (2)Individuals who have already received the influenza vaccine during this flu season; 3.Target population for the incentive-based implementation strategy: (1) Absent for =1 month due to various reasons; (2) Informal staff on secondment, rotation, or internship; (3) Seconded to participate in other work; (4) Engaged in other intervention studies aimed at improving vaccination rates; (5) Engaged in other implementation studies related to incentive interventions.

Design outcomes

Primary

MeasureTime frame
Fidelity of core component implementation of Rapid Verbal Intervention (RVP);Influenza vaccination status;

Secondary

MeasureTime frame
Fidelity of comprehensive implementation of RVP;Acceptability of RVP;Adaption of RVP;Cost;Sustainability of RVP;Sustainment of RVP;

Countries

China

Contacts

Public ContactDong Xu; Siyuan Liu

Southern Medical University

romanxu@i.smu.edu.cn+86 139 1098 8979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026